Results 11 to 20 of about 125,967 (307)

Keratoconus progression associated with hormone replacement therapy [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2019
Purpose: To report a postmenopausal patient with keratoconus who experienced significant progression after using hormone replacement therapy. Observations: A 51-year-old woman with previously stable keratoconus presented with acute disease progression ...
Giulia Coco   +2 more
exaly   +4 more sources

Hormone replacement therapy and the prevention of postmenopausal osteoporosis

open access: yesMenopause Review, 2014
Fracture prevention is one of the public health priorities worldwide. Estrogen deficiency is the major factor in the pathogenesis of postmenopausal osteoporosis, the most common metabolic bone disease.
Marco Gambacciani, Marco Levancini
doaj   +2 more sources

RETRACTED: Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis

open access: yesFrontiers in Endocrinology, 2021
BackgroundWe performed a meta-analysis to evaluate the efficacy and safety of weekly long-acting growth hormone replacement therapy compared to daily growth hormone in children with short stature.MethodsA systematic literature search up to April 2021 was
Liyan Ma   +6 more
doaj   +1 more source

Pregnancy Outcomes of Different Endometrial Preparation in Patients With a History of Cesarean Section

open access: yesFrontiers in Endocrinology, 2022
ObjectiveTo investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section: natural cycle treatment, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist ...
Run Xin Gan   +12 more
doaj   +1 more source

Hormone replacement therapy [PDF]

open access: yesBMJ, 2012
A 51 year old woman presents to her general practitioner with troublesome hot flushes and night sweats for the past eight months. She is sexually active and her last period was about 5 months ago. She has taken a number of over-the-counter preparations, but none have been effective.
Hickey, M., Elliott, C., Davison, S.
openaire   +3 more sources

Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis

open access: yesJournal of International Medical Research, 2021
Aim This retrospective study aimed to evaluate the predictive value of serum cancer antigen 125 (CA125) levels before hormone replacement therapy on pregnancy outcomes in women with adenomyosis undergoing frozen embryo transfer.
Ling Huang   +4 more
doaj   +1 more source

Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care [PDF]

open access: yes, 2001
Objective To determine whether a decision aid on hormone replacement therapy influences decision making and health outcomes.Design Randomised controlled trial.Setting 26 general practices in the United Kingdom.Participants 205 women considering hormone ...
Davis, H   +5 more
core   +1 more source

Hormone replacement therapy is associated with improved verbal declarative memory in healthy relatively recent postmenopausal women. [PDF]

open access: yes, 2006
The efficacy of Hormone Replacement Therapy (HRT) for cognitive health in postmenopausal women has been systematically questioned during the last decade.
Sünram-Lea, Sandra I.   +3 more
core   +1 more source

NONALCOHOLIC FATTY LIVER DISEASE IN MENOPAUSAL WOMEN

open access: yesArquivos de Gastroenterologia, 2013
Context Nonalcoholic Fatty Liver Disease (NAFLD) is common in postmenopausal women. It is associated with metabolic syndrome. However, the influence of hormone replacement therapy in NAFLD development in these women needs to be investigated.
Gesira Soares de Assis FLORENTINO   +5 more
doaj   +1 more source

Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone [PDF]

open access: yesEndocrinology and Metabolism, 2015
Hypoparathyroidism (HypoPT) is characterized by low serum calcium levels caused by an insufficient secretion of parathyroid hormone (PTH). Despite normalization of serum calcium levels by treatment with activated vitamin D analogues and calcium ...
Lars Rejnmark   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy